Home Newsletters Cell Therapy News Incorporation of Bacterial Immunoevasins to Protect Cell Therapies from Host Antibody-Mediated Immune...

Incorporation of Bacterial Immunoevasins to Protect Cell Therapies from Host Antibody-Mediated Immune Rejection

0
IdeS cleavage of host IgG averted Fc-dependent phagocytosis and lysis, and the residual F(ab’)2 fragments remained on the surface, providing cells with an inert shield from additional IgG deposition.
[Molecular Therapy]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version